Erik Harris, EVP & Chief Commercial Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 6,354 shares at $138.16 ($878K) on 2021-03-02, disclosed to the SEC on 2021-03-03.
Open-market sale of $878k RARE by EVP & Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $138.17 | 2,470 | $341K | 38.9% |
| 2 | $138.17 | 2,470 | $341K | 38.9% |
| 3 | $138.16 | 707 | $98K | 11.1% |
| 4 | $138.16 | 707 | $98K | 11.1% |
| Total | $138.17 avg | 6,354 | $878K | 100% |
| Filing → |
| RARE | SELL | 2024-03-05 | $513K | — | Filing → |
| RARE | SELL | 2023-09-06 | $228K | — | Filing → |
| RARE | SELL | 2023-06-21 | $15K | — | Filing → |